Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7

Bioorganic & Medicinal Chemistry
2020.0

Abstract

Histone-lysine N-methyltransferase SET7 emerged as a potential target for multiple cancers. In a virtual screening program used to explore new and potent inhibitors of SET7, compound 16 was discovered as a top hit with an IC<sub>50</sub> value of 6.02 μM. A further similarity search afforded a new compound 23, which exhibited better activity against SET7 with an IC<sub>50</sub> value of 1.96 μM. Importantly, compound 23 selectively inhibited the proliferation of MV4-11 cells. Comprehensively, compound 23 can serve as a lead for further identification and development of more potent SET7 inhibitors.

Knowledge Graph

Similar Paper

Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7
Bioorganic &amp; Medicinal Chemistry 2020.0
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening
Journal of Medicinal Chemistry 2015.0
Identifying Novel Selective Non-Nucleoside DNA Methyltransferase 1 Inhibitors through Docking-Based Virtual Screening
Journal of Medicinal Chemistry 2014.0
Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription
Journal of Medicinal Chemistry 2016.0
Identification of the KDM2/7 Histone Lysine Demethylase Subfamily Inhibitor and its Antiproliferative Activity
Journal of Medicinal Chemistry 2013.0
5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma
European Journal of Medicinal Chemistry 2021.0
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation
Bioorganic &amp; Medicinal Chemistry 2010.0
Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library
European Journal of Medicinal Chemistry 2020.0
4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2020.0
Steric structure–activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9
Bioorganic &amp; Medicinal Chemistry 2016.0